The Senhance® Surgical System is the first and only digital laparoscopy platform
Indications for Use: Senhance® Surgical System
The Senhance® Surgical System is intended to assist in the accurate control of laparoscopic instruments for visualization and endoscopic manipulation of tissue including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, mobilization and retraction. The Senhance Surgical System is intended for use in laparoscopic gynecological surgery, colorectal surgery, cholecystectomy, and inguinal hernia repair. The system is indicated for adult use. It is intended for use by trained physicians in an operating room environment in accordance with the Instructions for Use. The device is restricted to sale by or on the order of a physician.
The Senhance® Surgical System has received a CE Mark according to the Medical Device Directive and is intended to be used for laparoscopic surgery in the abdomen, pelvis and limited uses in the thoracic cavity excluding the heart and greater vessels. The system is indicated for adult use. The device is restricted to sale by or on the order of a physician.
TransEnterix Italy is the legal manufacturer for CE purposes.
RADIA articulating instrumentation is only currently available in CE Markets. Four manipulator arm configurations are only currently available in CE Markets.
Senhance was developed under a license of the European Commission Joint Research Centre.